Search research articles
Contact Us
Filters
Showing results (751-760 of 1,171) with videos related to
Page
of 118
Sort By:
Journal of Critical Care
|
May 18, 2012
Discordance between microcirculatory alterations and arterial pressure in patients with hemodynamic instability
Ryan C Arnold, R Phillip Dellinger, Joseph E Parrillo, et al.
International Journal of Molecular Sciences
|
December 1, 2020
The Role of Histone Acetylation-/Methylation-Mediated Apoptotic Gene Regulation in Hepatocellular Carcinoma
Pradeep Kumar Rajan, Utibe-Abasi Udoh, Juan D Sanabria, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
January 22, 2011
Phase II multicenter trial of voreloxin as second-line therapy in chemotherapy-sensitive or refractory small cell lung cancer
Lee M Krug, Jeffrey Crawford, David S Ettinger, et al.
BMC Nephrology
|
December 31, 2017
Systematic review of nephrotoxicity of drugs of abuse, 2005-2016
Kanaan Mansoor, Murad Kheetan, Saba Shahnawaz, et al.
American Journal of Physiology. Renal Physiology
|
January 30, 2009
The cardiotonic steroid hormone marinobufagenin induces renal fibrosis: implication of epithelial-to-mesenchymal transition
Larisa V Fedorova, Vanamala Raju, Nasser El-Okdi, et al.
British Journal of Cancer
|
March 21, 2013
Sunitinib in combination with gemcitabine for advanced solid tumours: a phase I dose-finding study
M D Michaelson, A X Zhu, D P Ryan, et al.
Cancer Immunology, Immunotherapy : CII
|
January 13, 2015
Cutaneous keratoacanthomas/squamous cell carcinomas associated with neutralization of transforming growth factor β by the monoclonal antibody fresolimumab (GC1008)
Mario E Lacouture, John C Morris, Donald P Lawrence, et al.
Eclinicalmedicine
|
April 20, 2026
Challenges in early detection and prognostication of sepsis: new approaches from the emergency department and intensive care unit
Thomas Lafon, Melanie Weingart, Julien Vaidie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 21, 2021
Opportunities for Utilization of DNA Repair Inhibitors in Homologous Recombination Repair-Deficient and Proficient Pancreatic Adenocarcinoma
James M Cleary, Brian M Wolpin, Stephanie K Dougan, et al.
Investigational New Drugs
|
August 2, 2020
A phase Ib open-label dose escalation study of the safety, pharmacokinetics, and pharmacodynamics of cobimetinib (GDC-0973) and ipatasertib (GDC-0068) in patients with locally advanced or metastatic solid tumors
Geoffrey I Shapiro, Patricia LoRusso, Daniel C Cho, et al.
Page
of 118
Search research articles
Search
Showing results (751-760 of 1,171) with videos related to
Sort By:
Page
of 118
Journal of Critical Care
|
May 18, 2012
Discordance between microcirculatory alterations and arterial pressure in patients with hemodynamic instability
Ryan C Arnold, R Phillip Dellinger, Joseph E Parrillo, et al.
International Journal of Molecular Sciences
|
December 1, 2020
The Role of Histone Acetylation-/Methylation-Mediated Apoptotic Gene Regulation in Hepatocellular Carcinoma
Pradeep Kumar Rajan, Utibe-Abasi Udoh, Juan D Sanabria, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
January 22, 2011
Phase II multicenter trial of voreloxin as second-line therapy in chemotherapy-sensitive or refractory small cell lung cancer
Lee M Krug, Jeffrey Crawford, David S Ettinger, et al.
BMC Nephrology
|
December 31, 2017
Systematic review of nephrotoxicity of drugs of abuse, 2005-2016
Kanaan Mansoor, Murad Kheetan, Saba Shahnawaz, et al.
American Journal of Physiology. Renal Physiology
|
January 30, 2009
The cardiotonic steroid hormone marinobufagenin induces renal fibrosis: implication of epithelial-to-mesenchymal transition
Larisa V Fedorova, Vanamala Raju, Nasser El-Okdi, et al.
British Journal of Cancer
|
March 21, 2013
Sunitinib in combination with gemcitabine for advanced solid tumours: a phase I dose-finding study
M D Michaelson, A X Zhu, D P Ryan, et al.
Cancer Immunology, Immunotherapy : CII
|
January 13, 2015
Cutaneous keratoacanthomas/squamous cell carcinomas associated with neutralization of transforming growth factor β by the monoclonal antibody fresolimumab (GC1008)
Mario E Lacouture, John C Morris, Donald P Lawrence, et al.
Eclinicalmedicine
|
April 20, 2026
Challenges in early detection and prognostication of sepsis: new approaches from the emergency department and intensive care unit
Thomas Lafon, Melanie Weingart, Julien Vaidie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 21, 2021
Opportunities for Utilization of DNA Repair Inhibitors in Homologous Recombination Repair-Deficient and Proficient Pancreatic Adenocarcinoma
James M Cleary, Brian M Wolpin, Stephanie K Dougan, et al.
Investigational New Drugs
|
August 2, 2020
A phase Ib open-label dose escalation study of the safety, pharmacokinetics, and pharmacodynamics of cobimetinib (GDC-0973) and ipatasertib (GDC-0068) in patients with locally advanced or metastatic solid tumors
Geoffrey I Shapiro, Patricia LoRusso, Daniel C Cho, et al.
Page
of 118